117
Participants
Start Date
May 31, 2007
Primary Completion Date
December 31, 2011
Study Completion Date
March 31, 2012
Tigan®
Oral capsule, 300mg three times daily
Placebo
Oral capsule, three times daily
Parkinson's Disease and Movement Disorders Center of Long Island, Commack
Kingston Neurological Associates, Kingston
Parkinson's & Movements Disorders Center of Maryland, Elkridge
Sentara Neurological Associates, Virginia Beach
Raleigh Neurology Associates, Raleigh
Emory University, Atlanta
Neurology Associates of Ormond Beach, Ormond Beach
University of Florida at Jacksonville, Jacksonville
Neurology at Shands Medical Center, Gainesville
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
USF Parkinson's Disease and Movement Disorders Center of Excellence, Tampa
Suncoast Neuroscience Associates, Inc., St. Petersburg
Charlotte Neurological Services, Port Charlotte
Neurological Institute, Cleveland Clinic, Cleveland
Quest Research Institute, Bingham Farms
Henry Ford Health System - Franklin Point, Southfield
Iowa Health Physicians, Des Moines
NorthShore University Health System, Glenview
Neurology Specialist of Dallas P.A, Dallas
East Texas Medical Center, Tyler
Parkinson's Disease and Movement Disorders Center, Baylor College of Medicine, Houston
Coastal Neurological Medical Group Inc., La Jolla
Neurology Associates, P.A., San Antonio
Barrow Neurological Movement Disorder Clinic, Phoenix
Mayo Clinic, Scottsdale
Neurosearch, Inc., Reseda
Neurosearch II, Inc., Ventura
Lead Sponsor
Collaborators (1)
INC Research Limited
INDUSTRY
Ipsen
INDUSTRY